• Science & Technology

Gene editing stem cells with CRISPR could help understand brain tumours

For the first time, scientists have used the gene-editing tool CRISPR to tweak the DNA of specialised brain stem cells, which could help us understand certain brain tumours better. For the first time, scientists have used the gene-editing tool CRISPR to tweak the DNA of specialised brain stem cells, which could help us understand certain brain tumours better.

14 February 2017

• Science & Technology
• Health & Medicine

3 of the toughest questions in cancer and more than £70 million to solve them

We're announcing the first winners of our most ambitious science funding awarding ever: The Grand Challenge We're announcing the first winners of our most ambitious science funding awarding ever: The Grand Challenge

10 February 2017

• Charity News
• Science & Technology

Cancer Research UK announces inaugural Grand Challenge teams to answer the biggest questions in cancer

Cancer Research UK announces that four international teams are the first recipients of its global Grand Challenge competition. Cancer Research UK announces that four international teams are the first recipients of its global Grand Challenge competition.

10 February 2017

• Health & Medicine

‘Magic’ blood test could make bone marrow transplants for blood cancer safer

A blood test could help predict the risk of complication following a bone marrow transplant in some blood cancer patients, according to a new US study. A blood test could help predict the risk of complication following a bone marrow transplant in some blood cancer patients, according to a new US study.

9 February 2017

• Science & Technology

Cancer Research Technology, UCL, and Tusk Therapeutics join forces to develop cancer immunotherapies

Cancer Research Technology, Tusk Therapeutics and UCL have signed an agreement to research, develop and commercialise an antibody-based therapeutic. Cancer Research Technology, Tusk Therapeutics and UCL have signed an agreement to research, develop and commercialise an antibody-based therapeutic.

7 February 2017

• Health & Medicine

World Cancer Day 2017: global lung cancer rates reveal tobacco’s dark shadow is looming

In the first of our 4-part series for this year’s World Cancer Day we take a look at lung cancer rates in different parts of the world. In the first of our 4-part series for this year’s World Cancer Day we take a look at lung cancer rates in different parts of the world.

6 February 2017

• Science & Technology

The biology of cancer cell shape and why it’s important

Why is the shape of a cancer cell so important for predicting how the disease will behave? Our scientists may have an answer. Why is the shape of a cancer cell so important for predicting how the disease will behave? Our scientists may have an answer.

1 February 2017

• Health & Medicine

Ovarian cancer drug could target gene fault in brain tumours

A genetic flaw that’s often found in a type of brain tumour may stop the cells from fixing damage to their DNA, findings from a new US study suggest. A genetic flaw that’s often found in a type of brain tumour may stop the cells from fixing damage to their DNA, findings from a new US study suggest.

1 February 2017

• Health & Medicine

Engineered immune cell treatment for childhood leukaemia may be a step closer

An immunotherapy treatment using genetically engineered cells has been used to successfully treat two infants with an aggressive kind of leukaemia. An immunotherapy treatment using genetically engineered cells has been used to successfully treat two infants with an aggressive kind of leukaemia.

27 January 2017

• Science & Technology

Genetic analysis of cervical cancers hints at targets for treatments

A large analysis of cervical tumour samples has found distinct genetic ‘signatures’ that could better define the disease. A large analysis of cervical tumour samples has found distinct genetic ‘signatures’ that could better define the disease.

25 January 2017

• Health & Medicine

Study establishes new standard of care for pancreatic cancer patients

A combination of two chemotherapy drugs should be the new standard of care for pancreatic cancer patients who have had surgery surgery to remove their tumour. A combination of two chemotherapy drugs should be the new standard of care for pancreatic cancer patients who have had surgery surgery to remove their tumour.

25 January 2017

• Health & Medicine

Scrambled DNA inside tumours might hinder cancer immunotherapy

Cancer treatments that harness the power of the immune system might be less effective in patients whose tumours carry incorrectly packaged DNA. Cancer treatments that harness the power of the immune system might be less effective in patients whose tumours carry incorrectly packaged DNA.

20 January 2017